Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] (2024)
- Authors:
- Autor USP: ULRICH, ALEXANDER HENNING - IQ
- Unidade: IQ
- DOI: 10.3389/fphar.2023.1355286
- Subjects: SISTEMA NERVOSO CENTRAL; DOENÇAS DO SISTEMA NERVOSO
- Agências de fomento:
- Financiamento NSFC
- Financiamento Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine
- Financiamento Sichuan Science and Technology Program
- Financiamento Sichuan Provincial Administration of Traditional Chinese Medicine
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Processo FAPESP: 2018/07366-4
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 14, p. 1-2 art. 1355286, 2024
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
TANG, Yong et al. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.3389/fphar.2023.1355286. Acesso em: 30 abr. 2024. , 2024 -
APA
Tang, Y., Rubini, P., Sperlagh, B., & Ulrich, H. (2024). Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2023.1355286 -
NLM
Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 abr. 30 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286 -
Vancouver
Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 abr. 30 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286 - Aluminum-induced alterations of purinergic signalling in embryonic neural progenitor cells
- SELEX for nuclease-resistant aptamers that inhibit P2X4 receptor function
- Neurociências
- Expression patterns of mesenchymal stem cell-specific proteins in adipose tissue-derived cells: possible immunosuppressing agent in partial allograft for restoring the urinary bladder in rabbits1
- Effects of resveratrol on the differentiation fate of neural progenitor cells of mouse embryos infected with Trypanosoma cruzi
- Aluminum affects neural phenotype determination of embryonic neural progenitor cells
- Mechanisms of neural differentiation and integration [Editorial]
- CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement
- Pharmacological reversal of synaptic and network pathology in human MECP2-KO neurons and cortical organoids
- Berberine increases the expression of cytokines and proteins linked to apoptosis in human melanoma cells
Informações sobre o DOI: 10.3389/fphar.2023.1355286 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 3186941.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
